tiprankstipranks
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
US Market

CytomX Therapeutics (CTMX) Financial Statements

Compare
646 Followers

CytomX Therapeutics Financial Overview

CytomX Therapeutics's market cap is currently $50.93M. The company's EPS TTM is $0.392; its P/E ratio is 1.48; CytomX Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 138.10M$ 101.21M$ 53.16M$ 69.57M$ 100.36M
Gross Profit$ 138.10M$ 101.21M$ 47.31M$ 63.73M$ 100.36M
Operating Income$ 25.00M$ -6.48M$ -101.33M$ -83.78M$ -48.60M
EBITDA$ 25.00M$ -4.31M$ -98.89M$ -113.34M$ -77.97M
Net Income$ 31.87M$ -569.00K$ -97.30M$ -80.65M$ -32.88M
Balance Sheet
Cash & Short-Term Investments$ 100.62M$ 174.51M$ 193.65M$ 305.23M$ 316.12M
Total Assets$ 120.53M$ 201.79M$ 260.89M$ 339.41M$ 358.66M
Total Debt$ 9.38M$ 13.97M$ 18.06M$ 18.06M$ 24.87M
Net Debt$ -28.67M$ -3.20M$ -175.59M$ -187.47M$ -166.99M
Total Liabilities$ 120.99M$ 249.24M$ 346.64M$ 250.03M$ 308.86M
Stockholders' Equity$ -456.00K$ -47.45M$ -85.75M$ 89.38M$ 49.80M
Cash Flow
Free Cash Flow$ -86.54M$ -56.88M$ -112.53M$ -120.64M$ 2.95M
Operating Cash Flow$ -86.23M$ -56.03M$ -110.79M$ -119.03M$ 5.26M
Investing Cash Flow$ 99.70M$ -150.67M$ 98.26M$ 22.49M$ -18.72M
Financing Cash Flow$ 7.52M$ 30.23M$ 648.00K$ 110.21M$ 16.89M
Currency in USD

CytomX Therapeutics Earnings and Revenue History

CytomX Therapeutics Debt to Assets

CytomX Therapeutics Cash Flow

CytomX Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis